Tizanidine extended release - Sun Pharma

Drug Profile

Tizanidine extended release - Sun Pharma

Alternative Names: SPARC 1401; Tizanidine ER

Latest Information Update: 13 Oct 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antispastics; Benzothiazoles; Imidazolines; Muscle relaxants; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Musculoskeletal pain

Most Recent Events

  • 13 Oct 2016 Sun Pharma Advanced Research Company completes a phase-II trial in Musculoskeletal pain (In volunteers) in Netherlands (EudraCT2015-003770-32) prior to October 2016
  • 20 Sep 2016 Sun Pharma Advanced Research Company plans a phase II trial for Back pain in USA (NCT02887534)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top